MARKET

FLNA

FLNA

Filana Therapeutics
NASDAQ
0.6207
-0.0373
-5.67%
Opening 14:40 10/30 EDT
OPEN
0.6585
PREV CLOSE
0.6580
HIGH
0.6585
LOW
0.6200
VOLUME
137.15K
TURNOVER
--
52 WEEK HIGH
3.940
52 WEEK LOW
0.6007
MARKET CAP
29.98M
P/E (TTM)
-0.7091
1D
5D
1M
3M
1Y
5Y
1D
Filana Therapeutics Announces A Study Published By Yale Researchers Of New Preclinical Research On Simufilam Examined Simufilam's Impacts In Human Cell Line To Eliminate Tuberous Sclerosis Complex 2 Gene To Model Cellular Changes
Benzinga · 2d ago
Weekly Report: what happened at FLNA last week (1019-1023)?
Weekly Report · 4d ago
Appeals Court Vacates Class Certification in Filana Case
TipRanks · 10/20 12:38
Filana Therapeutics Announces Fifth Circuit Rules Texas District Court Misapplied Legal Standard In Class Certification
Benzinga · 10/20 12:22
Weekly Report: what happened at FLNA last week (1012-1016)?
Weekly Report · 10/19 09:31
Weekly Report: what happened at FLNA last week (1005-1009)?
Weekly Report · 10/12 09:33
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
Barchart · 10/09 07:00
Weekly Report: what happened at FLNA last week (0928-1002)?
Weekly Report · 10/05 09:33
More
About FLNA
Filana Therapeutics, Inc., formerly Cassava Sciences, Inc., is a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, is an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.

Webull offers Filana Therapeutics Inc stock information, including NASDAQ: FLNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FLNA stock methods without spending real money on the virtual paper trading platform.